Skip to main content
FinSpry Logo
FinSpry
NPCE logo
NPCE
(NASDAQ)
NeuroPace, Inc.
$15.92-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

NeuroPace (NPCE) Stock Price & Financial Analysis

NeuroPace Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$15.22 - $15.87
52-Week High$19.60
52-Week Low$7.56
Open$15.56
Volume200.63K
Average Volume (3M)174.81K
Market Cap536.77M
Shares Outstanding33.72M
Price to Sales (P/S)5.39
Price to Book (P/B)37.14
EV/EBITDA-42.10
Revenue (TTM)99.53M
Net Income (TTM)-21.57M
Free Cash Flow (TTM)-9.84M
EPS (TTM)$-0.65
Profit Margin-21.67%
Operating Margin-16.84%
Return on Equity (ROE)-149.20%
Debt to Equity4.87
50-Day MA$16.30
200-Day MA$14.34
52-Week Change50.61%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About NeuroPace

What is the current stock price for NPCE?

As of the latest trading session, NPCE stock trades at $15.37. The 52-week range is $7.56–$19.60, with a day range of $15.22–$15.87.

What is the P/E ratio for NPCE?

The P/E ratio (Price-to-Earnings) for NPCE is shown in the Key Statistics section. This valuation metric helps compare NeuroPace, Inc. to industry peers.

Does NPCE pay dividends?

NeuroPace does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NPCE?

Based on 4 analysts, the consensus for NPCE is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NPCE?

NeuroPace's market capitalization is $518.2M, classifying it as a small-cap company. NeuroPace operates in the Healthcare sector within the Medical Devices industry.